deltatrials
Completed PHASE4 INTERVENTIONAL NCT00248300

A Peri-intubation Oral Intervention to Reduce Oral Flora and VAP

Sponsor: TriService Nursing Research Program

Conditions Pneumonia
Interventions Chlorhexidine
Updated 5 times since 2017 Last updated: Nov 9, 2015 Started: Aug 31, 2005 Primary completion: Aug 31, 2008 Completion: Aug 31, 2008
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00248300, this PHASE4 trial focuses on Pneumonia and remains completed. Sponsored by TriService Nursing Research Program, it has been updated 5 times since 2005, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE4

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE4

    First recorded

Aug 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • TriService Nursing Research Program
  • Uniformed Services University of the Health Sciences
  • United States Department of Defense
  • Virginia Commonwealth University
Data source: Virginia Commonwealth University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations